A generous donation to Icon Cancer Foundation is supporting research into innovative cellular therapies.
Icon Cancer Foundation is incredibly grateful for the support of an anonymous donor, whose generosity will help advance future research opportunities across Icon Cancer Centres in Australia, including the exploration of cellular therapies such as CAR T-cell therapy for myeloma.
What is CAR T-cell therapy?
CAR T-cell therapy is a cutting-edge form of immunotherapy that harnesses a patient's own immune system to target and destroy cancer cells.
Current evidence shows encouraging results in the treatment of blood cancers, and potentially other cancer types.
Across the globe, clinical trials are underway to explore and refine these new treatments, aiming to expand their effectiveness and accessibility.
Accessing CAR T-cell therapy in Australia
While CAR T-cell therapy has demonstrated significant promise for patients with blood cancers, access in Australia is limited to a small number of public hospitals due to the high cost.
Ongoing research and clinical trials are critical to advancing our understanding of these therapies and accelerating their availability for patients across Australia.
